ATORVASTATINE EVOLUGEN PHARMA 20 mg, comprimé pelliculé — plaquette(s) PVC aluminium polyamide de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930066485
  • CIP7 3006648
  • CIS 65689002

What the source publishes

Holder
EVOLUPHARM
Active ingredients
ATORVASTATINE, ATORVASTATINE CALCIQUE TRIHYDRATÉE
Form
comprimé pelliculé
Package
plaquette(s) PVC aluminium polyamide de 30 comprimé(s)
Routes
orale
Administrative status
cancelled
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2016-10-04
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930066485
{
  "cis": "65689002",
  "cip7": "3006648",
  "form": "comprimé pelliculé",
  "name": "ATORVASTATINE EVOLUGEN PHARMA 20 mg, comprimé pelliculé — plaquette(s) PVC aluminium polyamide de 30 comprimé(s)",
  "cip13": "3400930066485",
  "holder": "EVOLUPHARM",
  "routes": [
    "orale"
  ],
  "holders": [
    "EVOLUPHARM"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": "4.20",
  "authorisedOn": "2016-10-04",
  "compositions": [
    {
      "name": "ATORVASTATINE",
      "nature": "FT",
      "strength": "20 mg",
      "linkageNumber": "1",
      "substanceCode": "19809",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "ATORVASTATINE CALCIQUE TRIHYDRATÉE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "92464",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "3.18",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ATORVASTATINE EVOLUGEN PHARMA 20 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) PVC aluminium polyamide de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2022-01-04",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "cancelled",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ATORVASTATINE",
    "ATORVASTATINE CALCIQUE TRIHYDRATÉE"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation abrogée",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930066485"